Funding for this research was provided by:
Lundbeck LLC, Deerfield, IL, USA
Received: 2 February 2022
Accepted: 24 March 2022
First Online: 18 April 2022
: Approval for each study was provided by the independent ethics committee or institutional review board of the study sites. The studies were each conducted in accordance with Good Clinical Practice guidelines, the principles of the Declaration of Helsinki, and all applicable regulatory requirements. Patients provided written informed consent prior to initiation of any study procedures.
: Not applicable.
: R. Apelian is a member of the speaker bureau for Lundbeck; advisor/consultant/speaker for Allergan/Abbvie, Biohaven, and Eli Lilly.L. Boyle and D. Asher are full-time employees of Lundbeck.J. Hirman is an employee of Pacific Northwest Statistical Consulting, Inc., a contracted service provider of biostatistical resources for Lundbeck.